financetom
Business
financetom
/
Business
/
--KKR & Co Said to be Mulling $1 Billion Healthium Medtech Acquisition, Bloomberg Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--KKR & Co Said to be Mulling $1 Billion Healthium Medtech Acquisition, Bloomberg Reports
Apr 24, 2024 5:40 AM

08:20 AM EDT, 04/24/2024 (MT Newswires) --

Price: 98.25, Change: +0.28, Percent Change: +0.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Commerzbank on Overnight News
Commerzbank on Overnight News
Nov 8, 2024
06:13 AM EST, 11/08/2024 (MT Newswires) -- Commerzbank in its European Sunrise note of Friday highlighted: Markets: United States Treasuries stable in Asia after consolidating Federal Reserve gains, e-minis sideways after S&P closes on new high, Asian equities mixed. EURUSD falls back below 1.08 overnight, oil softer. Fed cuts by 25bps, unanimous decision. Chair Jerome Powell says he isn't ruling...
US Cellular to Sell Certain Spectrum Licenses to AT&T For $1.02 Billion
US Cellular to Sell Certain Spectrum Licenses to AT&T For $1.02 Billion
Nov 8, 2024
01:38 PM EST, 11/07/2024 (MT Newswires) -- US Cellular (USM) said Thursday it agreed to sell some of its spectrum licenses to telecommunications giant AT&T ( T ) for about $1.02 billion in cash. The tower operator said the deal is part of its plan to monetize the spectrum that was excluded from its May agreement with T-Mobile US (...
Atmus Filtration Technologies' Q3 Adjusted Earnings, Net Sales Rise; 2024 Guidance Revised
Atmus Filtration Technologies' Q3 Adjusted Earnings, Net Sales Rise; 2024 Guidance Revised
Nov 8, 2024
06:56 AM EST, 11/08/2024 (MT Newswires) -- Atmus Filtration Technologies ( ATMU ) reported Q3 adjusted earnings Friday of $0.61 per share, up from $0.52 a year earlier. Analysts polled by Capital IQ expected $0.52. Net sales for the quarter ended Sept. 30 were $403.7 million, up from $396.2 million a year earlier. Analysts surveyed by Capital IQ expected $403.4...
BRIEF-Allovir And Kalaris Therapeutics Announce Merger To Form Company Focused On Retinal Diseases
BRIEF-Allovir And Kalaris Therapeutics Announce Merger To Form Company Focused On Retinal Diseases
Nov 8, 2024
Nov 8 (Reuters) - Allovir Inc ( ALVR ): * ALLOVIR AND KALARIS THERAPEUTICS ANNOUNCE AGREEMENT FOR TRANSFORMATIONAL MERGER TO CREATE COMPANY FOCUSED ON DISEASES OF THE RETINA * ALLOVIR INC ( ALVR ) - TO ACQUIRE 100% OF KALARIS EQUITY INTEREST * ALLOVIR INC ( ALVR ) - STOCKHOLDERS TO OWN 25.05% OF COMBINED COMPANY POST-MERGER * ALLOVIR INC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved